Diagnosis and Treatment > Investigation > Aldosterone (plasma)

You are looking at 1 - 6 of 6 items

Yasufumi Seki Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Yasufumi Seki in
Google Scholar
PubMed
Close
,
Satoshi Morimoto Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Satoshi Morimoto in
Google Scholar
PubMed
Close
,
Naohiro Yoshida Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Naohiro Yoshida in
Google Scholar
PubMed
Close
,
Kanako Bokuda Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Kanako Bokuda in
Google Scholar
PubMed
Close
,
Nobukazu Sasaki Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Nobukazu Sasaki in
Google Scholar
PubMed
Close
,
Midori Yatabe Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Midori Yatabe in
Google Scholar
PubMed
Close
,
Junichi Yatabe Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Junichi Yatabe in
Google Scholar
PubMed
Close
,
Daisuke Watanabe Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Daisuke Watanabe in
Google Scholar
PubMed
Close
,
Satoru Morita Departments of Diagnostic Imaging and Nuclear Medicine, Tokyo, Japan

Search for other papers by Satoru Morita in
Google Scholar
PubMed
Close
,
Keisuke Hata Departments of Urology, Kidney Center, Tokyo, Japan

Search for other papers by Keisuke Hata in
Google Scholar
PubMed
Close
,
Tomoko Yamamoto Departments of Surgical Pathology, Tokyo Women’s Medical University, Tokyo, Japan

Search for other papers by Tomoko Yamamoto in
Google Scholar
PubMed
Close
,
Yoji Nagashima Departments of Surgical Pathology, Tokyo Women’s Medical University, Tokyo, Japan

Search for other papers by Yoji Nagashima in
Google Scholar
PubMed
Close
, and
Atsuhiro Ichihara Departments of Endocrinology and Hypertension, Tokyo, Japan

Search for other papers by Atsuhiro Ichihara in
Google Scholar
PubMed
Close

Summary

Primary aldosteronism (PA) is more common than expected. Aberrant adrenal expression of luteinizing hormone (LH) receptor in patients with PA has been reported; however, its physiological role on the development of PA is still unknown. Herein, we report two unique cases of PA in patients with untreated Klinefelter’s syndrome, characterized as increased serum LH, suggesting a possible contribution of the syndrome to PA development. Case 1 was a 39-year-old man with obesity and hypertension since his 20s. His plasma aldosterone concentration (PAC) and renin activity (PRA) were 220 pg/mL and 0.4 ng/mL/h, respectively. He was diagnosed as having bilateral PA by confirmatory tests and adrenal venous sampling (AVS). Klinefelter’s syndrome was suspected as he showed gynecomastia and small testes, and it was confirmed on the basis of a low serum total testosterone level (57.3 ng/dL), high serum LH level (50.9 mIU/mL), and chromosome analysis. Case 2 was a 28-year-old man who had untreated Klinefelter’s syndrome diagnosed in his childhood and a 2-year history of hypertension and hypokalemia. PAC and PRA were 247 pg/mL and 0.3 ng/mL/h, respectively. He was diagnosed as having a 10 mm-sized aldosterone-producing adenoma (APA) by AVS. In the APA, immunohistochemical analysis showed co-expression of LH receptor and CYP11B2. Our cases of untreated Klinefelter’s syndrome complicated with PA suggest that increased serum LH levels and adipose tissues, caused by primary hypogonadism, could contribute to PA development. The possible complication of PA in hypertensive patients with Klinefelter’s syndrome should be carefully considered.

Learning points:

  • The pathogenesis of primary aldosteronism is still unclear.

  • Expression of luteinizing hormone receptor has been reported in aldosterone-producing adenoma.

  • Serum luteinizing hormone, which is increased in patients with Klinefelter’s syndrome, might contribute to the development of primary aldosteronism.

Open access
G Leksic Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by G Leksic in
Google Scholar
PubMed
Close
,
A M Alduk Department of Radiology, University Hospital Centre Zagreb, Zagreb, Croatia

Search for other papers by A M Alduk in
Google Scholar
PubMed
Close
,
V Molnar Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by V Molnar in
Google Scholar
PubMed
Close
,
A Haxhiu Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by A Haxhiu in
Google Scholar
PubMed
Close
,
A Balasko Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by A Balasko in
Google Scholar
PubMed
Close
,
N Knezevic Department of Urology, Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia

Search for other papers by N Knezevic in
Google Scholar
PubMed
Close
,
T Dusek Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia

Search for other papers by T Dusek in
Google Scholar
PubMed
Close
, and
D Kastelan Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia

Search for other papers by D Kastelan in
Google Scholar
PubMed
Close

Summary

Primary aldosteronism (PA) is characterised by aldosterone hypersecretion and represents a common cause of secondary hypertension. During diagnostic evaluation, it is essential to determine the aetiology of PA since the treatment of unilateral and bilateral disease differs significantly. Adrenal vein sampling (AVS) has been implemented as a gold standard test for the diagnosis of PA subtype. However, due to the AVS complexity, costs and limited availability, many patients with PA are being treated based on the computed tomography (CT) findings. In this article, we present two patients with discrepant CT and AVS results, demonstrating that AVS is the only reliable method for localising the source of aldosterone excess.

Learning points:

  • CT is an unreliable method for distinguishing aldosterone-producing adenoma (APA) from bilateral adrenal hyperplasia (BAH).

  • CT can be misleading in defining lateralisation of the aldosterone excess in case of unilateral disease (APA).

  • AVS is the gold standard test for defining the PA subtype.

Open access
Su Ann Tee Department of Endocrinology, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK

Search for other papers by Su Ann Tee in
Google Scholar
PubMed
Close
,
Earn Hui Gan Department of Endocrinology, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK
Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK

Search for other papers by Earn Hui Gan in
Google Scholar
PubMed
Close
,
Mohamad Zaher Kanaan Departments of Ophthalmology, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK

Search for other papers by Mohamad Zaher Kanaan in
Google Scholar
PubMed
Close
,
David Ashley Price Departments of Infectious Disease and Tropical Medicine, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK

Search for other papers by David Ashley Price in
Google Scholar
PubMed
Close
,
Tim Hoare Radiology, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK

Search for other papers by Tim Hoare in
Google Scholar
PubMed
Close
, and
Simon H S Pearce Department of Endocrinology, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK
Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK

Search for other papers by Simon H S Pearce in
Google Scholar
PubMed
Close

Summary

Primary adrenal insufficiency secondary to syphilis is extremely rare, with only five cases being reported in the literature. We report a case of adrenal insufficiency as a manifestation of Treponema pallidum infection (tertiary syphilis). A 69-year-old, previously fit and well Caucasian male was found to have adrenal insufficiency after being admitted with weight loss, anorexia and postural dizziness resulting in a fall. Biochemical testing showed hyponatraemia, hyperkalaemia, and an inadequate response to Synacthen testing, with a peak cortisol level of 302 nmol/L after administration of 250 µg Synacthen. Abdominal imaging revealed bilateral adrenal hyperplasia with inguinal and retroperitoneal lymphadenopathy. He was started on hydrocortisone replacement; however, it was not until he re-attended ophthalmology with a red eye and visual loss 1 month later, that further work-up revealed the diagnosis of tertiary syphilis. Following a course of penicillin, repeat imaging 5 months later showed resolution of the abnormal radiological appearances. However, adrenal function has not recovered and 3 years following initial presentation, the patient remains on both glucocorticoid and mineralocorticoid replacement. In conclusion, this case highlights the importance of considering syphilis as a potential differential diagnosis in patients presenting with adrenal insufficiency and bilateral adrenal masses, given the recent re-emergence of this condition. The relative ease of treating infectious causes of adrenal lesions makes accurate and timely diagnosis crucial.

Learning points:

  • Infectious causes, including syphilis, should be excluded before considering adrenalectomy or biopsy for any patient presenting with an adrenal mass.

  • It is important to perform a full infection screen including tests for human immunodeficiency virus, other blood-borne viruses and concurrent sexually transmitted diseases in patients presenting with bilateral adrenal hyperplasia with primary adrenal insufficiency.

  • Awareness of syphilis as a potential differential diagnosis is important, as it not only has a wide range of clinical presentations, but its prevalence has been increasing in recent times.

Open access
M J Trott Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by M J Trott in
Google Scholar
PubMed
Close
,
G Farah Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by G Farah in
Google Scholar
PubMed
Close
,
V J Stokes Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by V J Stokes in
Google Scholar
PubMed
Close
,
L M Wang Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by L M Wang in
Google Scholar
PubMed
Close
, and
A B Grossman Radcliffe Department of Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by A B Grossman in
Google Scholar
PubMed
Close

Summary

We present a case of a young female patient with a rare cause of relapsing and remitting Cushing’s syndrome due to ectopic ACTH secretion from a thymic neuroendocrine tumour. A 34-year-old female presented with a constellation of symptoms of Cushing’s syndrome, including facial swelling, muscle weakness and cognitive impairment. We use the terms ‘relapsing and remitting’ in this case report, given the unpredictable time course of symptoms, which led to a delay of 2 years before the correct diagnosis of hypercortisolaemia. Diagnostic workup confirmed ectopic ACTH secretion, and a thymic mass was seen on mediastinal imaging. The patient subsequently underwent thymectomy with complete resolution of her symptoms. Several case series have documented the association of Cushing’s syndrome with thymic neuroendocrine tumours (NETs), although to our knowledge there are a few published cases of patients with relapsing and remitting symptoms. This case is also notable for the absence of features of the MEN-1 syndrome, along with the female gender of our patient and her history of non-smoking.

Learning points

  • Ectopic corticotrophin (ACTH) secretion should always be considered in the diagnostic workup of young patients with Cushing’s syndrome

  • There is a small but growing body of literature describing the correlation between ectopic ACTH secretion and thymic neuroendocrine tumours (NETs)

  • The possibility of a MEN-1 syndrome should be considered in all patients with thymic NETs, and we note the observational association with male gender and cigarette smoking in this cohort

  • An exception to these associations is the finding of relatively high incidence of thymic NETs among female non-smoking MEN-1 patients in the Japanese compared with Western populations

  • The relapsing and remitting course of our patient’s symptoms is noteworthy, given the paucity of this finding among other published cases

Open access
Ya-Wun Guo Department of Medicine, Taipei City Hospital, Zhongxing Branch, Taipei, Taiwan
Department of Medicine, Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan

Search for other papers by Ya-Wun Guo in
Google Scholar
PubMed
Close
,
Chii-Min Hwu Department of Medicine, Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

Search for other papers by Chii-Min Hwu in
Google Scholar
PubMed
Close
,
Justin Ging-Shing Won Department of Medicine, Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

Search for other papers by Justin Ging-Shing Won in
Google Scholar
PubMed
Close
,
Chia-Huei Chu Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
Department of Otorhinolaryngology-Head and Neck Surgery, Division of Otology, Taipei Veterans General Hospital, Taipei, Taiwan

Search for other papers by Chia-Huei Chu in
Google Scholar
PubMed
Close
, and
Liang-Yu Lin Department of Medicine, Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan

Search for other papers by Liang-Yu Lin in
Google Scholar
PubMed
Close

Summary

A functional lesion in corticotrophin (ACTH)-independent Cushing’s syndrome is difficult to distinguish from lesions of bilateral adrenal masses. Methods for distinguishing these lesions include adrenal venous sampling and 131I-6β-iodomethyl-19-norcholesterol (131I-NP-59) scintigraphy. We present a case of a 29-year-old Han Chinese female patient with a history of hypercholesterolaemia and polycystic ovary syndrome. She presented with a 6month history of an 8kg body weight gain and gradual rounding of the face. Serial examinations revealed loss of circadian rhythm of cortisol, elevated urinary free-cortisol level and undetectable ACTH level (<5pg/mL). No suppression was observed in both the low- and high-dose dexamethasone suppression tests. Adrenal computed tomography revealed bilateral adrenal masses. Adrenal venous sampling was performed, and the right-to-left lateralisation ratio was 14.29. The finding from adrenal scintigraphy with NP-59 was consistent with right adrenal adenoma. The patient underwent laparoscopic right adrenalectomy, and the pathology report showed adrenocortical adenoma. Her postoperative cortisol level was 3.2μg/dL, and her Cushingoid appearance improved. In sum, both adrenal venous sampling and 131I-NP-59 scintigraphy are good diagnostic methods for Cushing’s syndrome presenting with bilateral adrenal masses.

Learning points

  • The clinical presentation of Cushing’ syndrome includes symptoms and signs of fat redistribution and protein-wasting features.

  • The diagnosis of patients with ACTH-independent Cushing’s syndrome with bilateral adrenal masses is challenging for localisation of the lesion.

  • Both adrenal venous sampling and 131I-NP-59 scintigraphy are good methods to use in these patients with Cushing’s syndrome presenting with bilateral adrenal masses.

Open access
Tohru Eguchi Department of Internal Medicine, Uwajima City Hospital, 1-1 Gotenmachi, Uwajima, Ehime, 798-8510, Japan

Search for other papers by Tohru Eguchi in
Google Scholar
PubMed
Close
and
Shozo Miyauchi Department of Internal Medicine, Uwajima City Hospital, 1-1 Gotenmachi, Uwajima, Ehime, 798-8510, Japan

Search for other papers by Shozo Miyauchi in
Google Scholar
PubMed
Close

Summary

A 43-year-old Japanese woman was admitted to our hospital with weakness. Laboratory findings showed hypokalemia, hypocalcemia and elevation of the serum creatinine phosphokinase levels, but intact parathyroid hormone levels. Further evaluations suggested that she had primary aldosteronism (PA), secondary hyperparathyroidism and bilateral adrenal tumors. She was treated successfully by laparoscopic right adrenalectomy. This case not only serves to the diagnosis of bilateral adrenal tumors in which selective adrenal venous sampling (SAVS) proved to be useful, but also for physicians to be aware of secondary hyperparathyroidism and the risk of secondary osteoporosis caused by PA.

Learning points

  • The classic presenting signs of PA are hypertension and hypokalemia.

  • Hypokalemia can induce rhabdomyolysis.

  • PA causes secondary hyperparathyroidism.

  • Patients with PA have the risk of osteoporosis with secondary hyperparathyroidism.

  • SAVS is useful in bilateral adrenal tumors.

Open access